Capital Advisors Inc. OK Sells 599 Shares of McKesson Corporation (NYSE:MCK)

Capital Advisors Inc. OK lowered its stake in shares of McKesson Corporation (NYSE:MCK - Free Report) by 40.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 872 shares of the company's stock after selling 599 shares during the period. Capital Advisors Inc. OK's holdings in McKesson were worth $587,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Capital A Wealth Management LLC purchased a new stake in shares of McKesson during the fourth quarter worth $26,000. Millstone Evans Group LLC purchased a new stake in shares of McKesson during the fourth quarter worth $28,000. Atala Financial Inc purchased a new stake in shares of McKesson during the fourth quarter worth $34,000. Graney & King LLC purchased a new stake in shares of McKesson during the fourth quarter worth $38,000. Finally, CoreFirst Bank & Trust purchased a new stake in shares of McKesson during the fourth quarter worth $67,000. Hedge funds and other institutional investors own 85.07% of the company's stock.

Analyst Ratings Changes

Several research firms have issued reports on MCK. Mizuho increased their target price on McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a research report on Thursday, April 3rd. Morgan Stanley upped their price target on shares of McKesson from $745.00 to $770.00 and gave the stock an "overweight" rating in a report on Wednesday, June 11th. UBS Group upped their price target on shares of McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Evercore ISI upped their price target on shares of McKesson from $760.00 to $800.00 and gave the stock an "outperform" rating in a report on Wednesday. Finally, Cfra Research cut shares of McKesson from a "moderate buy" rating to a "hold" rating in a report on Friday, April 4th. Three research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $706.83.

McKesson Stock Performance

MCK traded down $7.02 during trading on Friday, reaching $707.52. The stock had a trading volume of 77,662 shares, compared to its average volume of 925,220. The stock has a market cap of $88.52 billion, a PE ratio of 27.40, a PEG ratio of 1.45 and a beta of 0.48. McKesson Corporation has a one year low of $464.42 and a one year high of $737.89. The business has a 50-day moving average of $715.65 and a 200-day moving average of $661.24.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $10.12 EPS for the quarter, beating analysts' consensus estimates of $9.83 by $0.29. The business had revenue of $90.82 billion for the quarter, compared to analysts' expectations of $94 billion. McKesson had a negative return on equity of 201.12% and a net margin of 0.92%. The firm's revenue was up 18.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.18 earnings per share. Equities research analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, July 1st. Stockholders of record on Monday, June 2nd were paid a dividend of $0.71 per share. The ex-dividend date was Monday, June 2nd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.40%. McKesson's dividend payout ratio (DPR) is currently 10.99%.

Insider Transactions at McKesson

In other McKesson news, CFO Britt J. Vitalone sold 6,336 shares of McKesson stock in a transaction that occurred on Thursday, May 22nd. The stock was sold at an average price of $717.30, for a total value of $4,544,812.80. Following the transaction, the chief financial officer directly owned 14,760 shares of the company's stock, valued at $10,587,348. The trade was a 30.03% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Thomas L. Rodgers sold 2,891 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $712.18, for a total value of $2,058,912.38. Following the sale, the executive vice president directly owned 2,544 shares of the company's stock, valued at approximately $1,811,785.92. This trade represents a 53.19% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,117 shares of company stock valued at $23,526,451. 0.08% of the stock is currently owned by corporate insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.